Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.48ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.48NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.47.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.47.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.47.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.47.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.29.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.29.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.29.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.29.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.24.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.24.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.24.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.24.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.18.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.18.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LU.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.59ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used